TJL Pharmaceutical has announced the launch of LifeSol NSAID, an intravenous ibuprofen infusion delivering 400mg in a precision 100ml ready-to-use format. The launch marks a significant expansion of the company's therapeutic infusion range manufactured at its Kabul facility.
Why IV Ibuprofen Matters
For patients with moderate to severe acute pain — or those who cannot take oral medication — intravenous delivery provides a rapid onset of action with precise dosing. LifeSol NSAID delivers ibuprofen directly into the bloodstream, providing fast and sustained relief of pain, fever and inflammation.
The ready-to-infuse format removes dilution steps at the bedside, reducing preparation time and eliminating dilution errors — a meaningful safety gain for busy hospital wards and emergency departments.
Manufactured Under cGMP
Like every LifeSol product, each batch of LifeSol NSAID is terminally sterilized, pyrogen-free and released only after full sterility, particulate and chemical testing in TJL's in-house quality control laboratories.
LifeSol NSAID is available now for hospitals and distributors. Contact the TJL export team for registration status and availability in your market.
Interested in this product or partnership?
Our export team responds to all enquiries within one business day.
